A Maryland native who was born with dwarfism and endured painful months-long limb-lengthening procedures is using her experience (and new look) to raise awareness for the genetic disorder. Chandler ...

Chandler Crews, now 31 and based in Maryland, first underwent limb-lengthening surgery at 16 to address challenges caused by achondroplasia—a genetic condition that impairs bone growth, often ...

A drug that boosts bone growth in children with the most common form of dwarfism, may also reduce their chances of sudden infant death syndrome, sleep apnea and needing surgery, according to a new ...

Until an ultrasound scan at 20 weeks, Samantha Anderson’s second pregnancy had been going according to plan. That scan revealed that her baby had some excess fluid in their skull. The physician wasn’t ...

Chandler Crews knew she didn't want to live her entire adult life less than four feet tall. The 31-year-old from Maryland was born with achondroplasia, a genetic condition that most commonly results ...

Achondroplasia is a genetic skeletal condition that results in disproportionately short stature and medical complications throughout life. Infigratinib is an orally bioavailable FGFR1–3 selective ...

COPENHAGEN, Denmark, May 13, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (ASND) today announced new data showing improvements in growth and bone morphometry from Week 52 of its pivotal ApproaCH Trial ...

Phase 3 findings show infigratinib significantly improved annualized height velocity vs placebo in children living with achondroplasia. Topline data were announced from a phase 3 trial evaluating ...

Children of all ages with achondroplasia are now included in the expanded Indication, the most common form of skeletal dysplasia leading to disproportionate short stature. This article was originally ...

Please provide your email address to receive an email when new articles are posted on . Children with achondroplasia achieved 1.49 cm per year greater increase in annualized growth velocity with ...